Equities research analysts at Citigroup began coverage on shares of athenahealth (NASDAQ:ATHN) in a note issued to investors on Thursday, January 4th, The Fly reports. The firm set a “neutral” rating on the health services provider’s stock.
Several other equities research analysts have also recently weighed in on the stock. Wells Fargo & Co cut their price objective on shares of athenahealth from $190.00 to $155.00 and set an “outperform” rating for the company in a research report on Monday, October 23rd. Oppenheimer reissued a “buy” rating and set a $184.00 target price on shares of athenahealth in a research note on Friday, October 20th. KeyCorp reaffirmed a “buy” rating and issued a $170.00 price objective on shares of athenahealth in a research note on Sunday, September 17th. TheStreet cut athenahealth from a “b-” rating to a “c+” rating in a report on Wednesday, October 11th. Finally, First Analysis upgraded athenahealth from an “underweight” rating to an “equal weight” rating and increased their price target for the stock from $125.00 to $127.00 in a report on Monday, October 23rd. One investment analyst has rated the stock with a sell rating, seventeen have assigned a hold rating and nine have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $143.96.
Shares of athenahealth (ATHN) traded down $3.18 on Thursday, reaching $129.47. 509,317 shares of the company’s stock were exchanged, compared to its average volume of 297,463. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.67 and a current ratio of 1.67. athenahealth has a 1 year low of $95.01 and a 1 year high of $158.66. The company has a market capitalization of $5,308.35, a price-to-earnings ratio of 168.14, a P/E/G ratio of 3.10 and a beta of 1.58.
athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The business had revenue of $304.60 million for the quarter, compared to the consensus estimate of $310.52 million. During the same period in the previous year, the company earned $0.60 earnings per share. The firm’s revenue for the quarter was up 10.1% on a year-over-year basis. research analysts forecast that athenahealth will post 1.22 EPS for the current year.
In related news, Director Amy Abernethy sold 500 shares of the stock in a transaction that occurred on Tuesday, December 26th. The stock was sold at an average price of $134.18, for a total transaction of $67,090.00. Following the completion of the transaction, the director now directly owns 4,045 shares of the company’s stock, valued at $542,758.10. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Jonathan Bush sold 30,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 26th. The shares were sold at an average price of $134.80, for a total value of $4,044,000.00. Following the completion of the sale, the chief executive officer now directly owns 320,807 shares of the company’s stock, valued at $43,244,783.60. The disclosure for this sale can be found here. In the last 90 days, insiders sold 69,700 shares of company stock valued at $9,375,172. Company insiders own 3.20% of the company’s stock.
Hedge funds have recently modified their holdings of the stock. Elliott Management Corp purchased a new position in athenahealth during the 2nd quarter worth $52,706,000. UBS Asset Management Americas Inc. boosted its position in shares of athenahealth by 33.2% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 30,536 shares of the health services provider’s stock worth $4,292,000 after purchasing an additional 7,605 shares in the last quarter. Rockefeller Financial Services Inc. boosted its position in shares of athenahealth by 293.2% in the 3rd quarter. Rockefeller Financial Services Inc. now owns 9,110 shares of the health services provider’s stock worth $1,133,000 after purchasing an additional 6,793 shares in the last quarter. Toronto Dominion Bank boosted its position in shares of athenahealth by 83.3% in the 3rd quarter. Toronto Dominion Bank now owns 220,000 shares of the health services provider’s stock worth $27,356,000 after purchasing an additional 100,000 shares in the last quarter. Finally, Perceptive Advisors LLC acquired a new stake in shares of athenahealth in the 3rd quarter worth $8,705,000.
ILLEGAL ACTIVITY WARNING: “athenahealth (NASDAQ:ATHN) Research Coverage Started at Citigroup” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/13/athenahealth-athn-coverage-initiated-at-citigroup.html.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.